Comparison of the Mortality Prediction Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in COVID-19 and Sepsis
In the last years, biomarkers of infection, such as the soluble urokinase plasminogen activator receptor (suPAR), have been extensively studied as potential diagnostic and prognostic biomarkers in the intensive care unit (ICU). In this study, we investigated whether this biomarker can be used in COV...
Main Authors: | Alice G. Vassiliou, Alexandros Zacharis, Charikleia S. Vrettou, Chrysi Keskinidou, Edison Jahaj, Zafeiria Mastora, Stylianos E. Orfanos, Ioanna Dimopoulou, Anastasia Kotanidou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/5/1261 |
Similar Items
-
Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department
by: Pratyush Kumar, et al.
Published: (2019-01-01) -
Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Analysis for Diagnosis of Periprosthetic Joint Infection
by: Sebastian M. Klim, et al.
Published: (2024-02-01) -
Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
by: Mariangela Manfredi, et al.
Published: (2023-04-01) -
Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
by: Charlotte Höybye, et al.
Published: (2019-05-01) -
Sex Differences in Circulating Soluble Urokinase‐Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease
by: Anurag Mehta, et al.
Published: (2020-03-01)